Vickie Yi Zhang1,2, Mark Swanson1,
Laura Tabatabai3, Jeff Simko3,
1Radiology, University of California,
San Francisco, San Francisco, CA, United States; 2Joint
Bioengineering Program, University of California, Berkeley/San Francisco, San Francisco, CA, United
States; 3Pathology, University of California, San Francisco, San
Francisco, CA, United States
Synopsis:
This study used quantitative 1-D 1H HR-MAS spectroscopy of snap frozen
prostate biopsies to investigate the metabolic profiles of healthy versus
cancer prostate tissues after radiation therapy. Metabolite concentrations
were correlated with pathology and Ki-67 immunohistochemistry to identify a
metabolic phenotype of proliferating residue cancer. Significantly higher concentrations of
PC+GPC, lactate and glutamate were observed in benign versus residual
proliferating cancer tissues after radiation treatment.